ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,399, issued on Dec. 16, was assigned to INSULET Corp. (Acton, Mass.).

"Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk" was invented by Joon Bok Lee (Acton, Mass.), Ashutosh Zade (San Diego), Jason O'Connor (Acton, Mass.), Trang Ly (Concord, Mass.), Yibin Zheng (Hartland, Wis.), Connor Gullifer (Brighton, Mass.) and Kyle Grover (Watertown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The exemplary embodiments attempt to identify impending hypoglycemia and/or hyperglycemia and take measures to prevent the hypoglycemia or hyperglycemia. Exemplary embodiments may provide a drug delivery system for deli...